Dr. Kristen Erickstad, MD
What this data tells you about Dr. Erickstad
Dr. Kristen Erickstad is a rheumatology in Longview, TX, with 14 years in practice. Based on federal Medicare data, Dr. Erickstad performed 29,520 Medicare services across 3,230 unique beneficiaries.
Between the years covered by Open Payments, Dr. Erickstad received a total of $10,908 from 52 pharmaceutical and/or device companies across 755 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Erickstad is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 13,020 | $8 | $28 |
| Denosumab injection (Prolia/Xgeva) | 10,500 | $18 | $65 |
| Blood draw (venipuncture) | 839 | $8 | $20 |
| Office visit, established patient (30-39 min) | 779 | $86 | $200 |
| Comprehensive metabolic blood panel | 700 | $10 | $105 |
| C-reactive protein test (inflammation marker) | 613 | $5 | $28 |
| Sed rate test (inflammation marker) | 599 | $3 | $20 |
| Complete blood count (CBC) with differential | 553 | $8 | $40 |
| Drug injection, under skin or into muscle | 280 | $10 | $50 |
| Administration of chemotherapy into vein, 1 hour or less | 215 | $91 | $315 |
| Vitamin D level test | 197 | $29 | $140 |
| Office visit, established patient (20-29 min) | 185 | $64 | $135 |
| New patient office visit (45-59 min) | 181 | $113 | $310 |
| Administration of chemotherapy into vein, each additional hour | 164 | $21 | $200 |
| Rheumatoid factor level | 105 | $5 | $55 |
| Bone density scan (DEXA) | 92 | $29 | $88 |
| Injection, zoledronic acid, 1 mg | 90 | $6 | $199 |
| Uric acid level test | 60 | $4 | $25 |
| X-ray of hand, minimum of 3 views | 53 | $20 | $64 |
| Shoulder X-ray, 2+ views | 36 | $20 | $59 |
| Creatine kinase (cardiac enzyme) level, total | 31 | $6 | $27 |
| Knee X-ray, 3 views | 29 | $22 | $77 |
| X-ray of lower and sacral spine, minimum of 4 views | 27 | $28 | $107 |
| Flu vaccine administration | 22 | $29 | $31 |
| New patient office visit (30-44 min) | 19 | $74 | $200 |
| Flu vaccine, high-dose | 18 | $72 | $85 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 18 | $43 | $200 |
| X-ray of joint between lower spine and hip bone, 3 or more views | 14 | $17 | $79 |
| Hip X-ray, 2-3 views | 12 | $23 | $101 |
| Liver function blood test panel | 12 | $8 | $51 |
| Thyroid stimulating hormone (TSH) test | 12 | $16 | $70 |
| Hepatitis c antibody measurement | 12 | $12 | $85 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 11 | $282 | $305 |
| Office visit, established patient, complex (40-54 min) | 11 | $125 | $270 |
| Pneumonia vaccine administration | 11 | $29 | $30 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Erickstad is a mixed practice specialist, with above-average Medicare volume (top 29% in TX), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Erickstad experienced with romosozumab injection (evenity) for osteoporosis?
Does Dr. Erickstad receive payments from pharmaceutical companies?
How do Dr. Erickstad's costs compare to other rheumatologys in Longview?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology